Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2025-12-25 @ 3:52 AM
NCT ID:
NCT00757302
Eligibility Criteria:
Inclusion Criteria:
* Patient major at the time of breast surgery.
* Patient affiliated with a social security.
* Consent dated and signed by the investigator and the subject.
* Subject having been informed of the sentinel lymph node procedure during the visit prior to breast surgery.
* Patient having a unifocal infiltrative breast cancer (less than 2 cm) diagnosed preoperatively by core biopsy or cytology.
* Patient having a ductal carcinoma in situ (DCIS), diagnosed preoperatively by core biopsy or cytology.
Exclusion Criteria:
* Refusal of the patient to be included in the study.
* Pregnant patient or during breastfeeding.
* None of the patients will have undergone chemotherapy, locoregional radiotherapy or prevalent axillary lymph node.
* Diagnosed safeguarding justice and trust.
* Patient with a psychiatric disorder makes it impossible for the collection of informed consent-patient with tumors greater than 2 cm or multifocal.
* Prevalent axillary lymph node.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00757302
Study Brief:
Protocol Section:
NCT00757302